Our microchemical facility at Caltech has exceeded all expectations in being able to sequence small quantities of protein and synthesize small or large fragments of genes. Several gas phase microsequenators are now functional and each has the capacity to sequence 20 or so residues a day. We have a DNA synthesizer with a three column system that has the capacity to synthesize simultaneously three oligonucleotides with a 14 min. cycle time. Thus, the microchemical facility has the considerable ability to sequence proteins and synthesize genes. These abilities have been turned to a variety of projects that are directly related to the cancer problem. Microsequencing done in this facility on platelet derived growth factor demonstrated for the first time the serum polypeptide hormone appears to be strikingly homologous to the primate oncogene. We are now in the process of analyzing the sequences of a series of other growth hormones and will have the opportunity to determine whether additional similar correlations can be made. We have also started to analyze the gene structure organization and rearrangements of genetic elements in coding the T cell receptor. Once again this receptor molecule plays a central role in facilitating the immune response against foreign invaders including tumors. The microchemical facility has been used to synthesize a wide range of DNA probes that have been used to clone the corresponding genes (partially documented in the Progress Report). Indeed, the DNA synthesizer has been used to synthesize an entire functional E. coli serine tRNA gene. The computer facility has added valuable backup and data analysis capacity to these and many other projects. The cell sorter is functional and has provided valuable data for a number of different laboratories. Within the next year we expect to have a fully functional automated peptide synthesizer and be well along in developing an automated DNA sequenator. Thus, this complement of instruments will allow us to both sequence and synthesize genes and DNA in a sensitive and rapid fashion. This year the microchemical facility has been used by more than 15 professors at Caltech and a much larger number of investigators outside the Institute.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA032911-07
Application #
3101756
Study Section
Cancer Center Support Review Committee (CCS)
Project Start
1983-08-01
Project End
1992-03-31
Budget Start
1990-04-01
Budget End
1991-03-31
Support Year
7
Fiscal Year
1990
Total Cost
Indirect Cost
Name
California Institute of Technology
Department
Type
Schools of Arts and Sciences
DUNS #
078731668
City
Pasadena
State
CA
Country
United States
Zip Code
91125
Garrity, P A; Chen, D; Rothenberg, E V et al. (1994) Interleukin-2 transcription is regulated in vivo at the level of coordinated binding of both constitutive and regulated factors. Mol Cell Biol 14:2159-69
Chen, D; Rothenberg, E V (1994) Interleukin 2 transcription factors as molecular targets of cAMP inhibition: delayed inhibition kinetics and combinatorial transcription roles. J Exp Med 179:931-42
Rothenberg, E V; Chen, D; Diamond, R A (1993) Functional and phenotypic analysis of thymocytes in SCID mice. Evidence for functional response transitions before and after the SCID arrest point. J Immunol 151:3530-46
Chen, D; Rothenberg, E V (1993) Molecular basis for developmental changes in interleukin-2 gene inducibility. Mol Cell Biol 13:228-37
Rothenberg, E V (1992) The development of functionally responsive T cells. Adv Immunol 51:85-214
Novak, T J; Chen, D; Rothenberg, E V (1990) Interleukin-1 synergy with phosphoinositide pathway agonists for induction of interleukin-2 gene expression: molecular basis of costimulation. Mol Cell Biol 10:6325-34
Rothenberg, E V; Diamond, R A; Pepper, K A et al. (1990) IL-2 gene inducibility in T cells before T cell receptor expression. Changes in signaling pathways and gene expression requirements during intrathymic maturation. J Immunol 144:1614-24
Boyer, P D; Diamond, R A; Rothenberg, E V (1989) Changes in inducibility of IL-2 receptor alpha-chain and T cell-receptor expression during thymocyte differentiation in the mouse. J Immunol 142:4121-30
Boyer, P D; Rothenberg, E V (1988) IL-2 receptor inducibility is blocked in cortical-type thymocytes. J Immunol 140:2886-92
Aebersold, R H; Leavitt, J; Saavedra, R A et al. (1987) Internal amino acid sequence analysis of proteins separated by one- or two-dimensional gel electrophoresis after in situ protease digestion on nitrocellulose. Proc Natl Acad Sci U S A 84:6970-4

Showing the most recent 10 out of 16 publications